GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Apr 2015 01:59 PM
RNS
Director/PDMR Shareholding
14 Apr 2015 03:36 PM
RNS
Director/PDMR Shareholding
14 Apr 2015 09:35 AM
RNS
Director/PDMR Shareholding
13 Apr 2015 06:30 PM
RNS
Director/PDMR Shareholding
13 Apr 2015 03:32 PM
RNS
Director/PDMR Shareholding
13 Apr 2015 02:41 PM
RNS
Director/PDMR Shareholding
13 Apr 2015 02:39 PM
RNS
Director/PDMR Shareholding
10 Apr 2015 02:37 PM
RNS
Director/PDMR Shareholding
08 Apr 2015 01:21 PM
RNS
Director/PDMR Shareholding
01 Apr 2015 04:10 PM
RNS
Director/PDMR Shareholding
01 Apr 2015 10:33 AM
RNS
Total Voting Rights
30 Mar 2015 04:46 PM
RNS
Director/PDMR Shareholding
25 Mar 2015 12:00 PM
RNS
Notice of AGM
20 Mar 2015 07:00 AM
RNS
US FDA Advisory Committee on BREO ELLIPTA
19 Mar 2015 02:26 PM
RNS
Director Declaration
16 Mar 2015 03:23 PM
RNS
Director/PDMR Shareholding
13 Mar 2015 07:00 AM
RNS
GSK completes partial sale of Aspen
12 Mar 2015 03:14 PM
RNS
GSK intends to sell part holding in Aspen
11 Mar 2015 04:35 PM
RNS
Director/PDMR Shareholding
11 Mar 2015 04:27 PM
RNS
Director/PDMR Shareholding
09 Mar 2015 05:33 PM
RNS
Director/PDMR Shareholding
06 Mar 2015 05:48 PM
RNS
Director/PDMR Shareholding
02 Mar 2015 02:38 PM
RNS
Director/PDMR Shareholding
02 Mar 2015 01:30 PM
RNS
Annual Report 2014 on Form 20-F
02 Mar 2015 11:40 AM
RNS
Total Voting Rights
02 Mar 2015 07:00 AM
RNS
GSK completes major three-part transaction
26 Feb 2015 04:03 PM
RNS
Annual Financial Report
26 Feb 2015 03:16 PM
RNS
Directorate Change
25 Feb 2015 04:21 PM
RNS
Update on three-part transaction with Novartis
20 Feb 2015 01:14 PM
RNS
Director/PDMR Shareholding
20 Feb 2015 11:57 AM
RNS
Director/PDMR Shareholding
19 Feb 2015 06:09 PM
RNS
Director/PDMR Shareholding
19 Feb 2015 06:09 PM
RNS
Director/PDMR Shareholding
18 Feb 2015 05:05 PM
RNS
Director/PDMR Shareholding
18 Feb 2015 05:00 PM
RNS
Director/PDMR Shareholding
17 Feb 2015 05:43 PM
RNS
Director/PDMR Shareholding
17 Feb 2015 05:40 PM
RNS
Director/PDMR Shareholding
17 Feb 2015 05:06 PM
RNS
Director/PDMR Shareholding
16 Feb 2015 03:05 PM
RNS
Director/PDMR Shareholding
13 Feb 2015 05:36 PM
RNS
Director/PDMR Shareholding
13 Feb 2015 03:39 PM
RNS
Director/PDMR Shareholding
12 Feb 2015 06:21 PM
RNS
Director/PDMR Shareholding
12 Feb 2015 06:21 PM
RNS
Director/PDMR Shareholding
12 Feb 2015 06:19 PM
RNS
Director/PDMR Shareholding
11 Feb 2015 02:30 PM
RNS
Director/PDMR Shareholding
06 Feb 2015 07:00 AM
RNS
Positive results from phase III COMBI-d study
05 Feb 2015 07:00 AM
RNS
Completion of Accelerated Bookbuild Offering
04 Feb 2015 04:05 PM
RNS
Accelerated Bookbuild Offering - Genmab A/S
04 Feb 2015 12:00 PM
RNS
Final Results
04 Feb 2015 11:06 AM
RNS
Total Voting Rights - Replacement

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings